Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Gilead Sciences Other Non-Current Liabilities 2010-2025 | GILD

Gilead Sciences other non-current liabilities from 2010 to 2025. Other non-current liabilities can be defined as field containing the sum of all non-current liabilities that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
  • Gilead Sciences other non-current liabilities for the quarter ending June 30, 2025 were $2.149B, a 0.32% decline year-over-year.
  • Gilead Sciences other non-current liabilities for 2024 were $0.83B, a 59.29% decline from 2023.
  • Gilead Sciences other non-current liabilities for 2023 were $2.039B, a 47.93% decline from 2022.
  • Gilead Sciences other non-current liabilities for 2022 were $3.916B, a 17.85% decline from 2021.
  
Gilead Sciences Annual Other Non-Current Liabilities
(Millions of US $)
2024 $830
2023 $2,039
2022 $3,916
2021 $4,767
2020 $5,016
2019 $6,115
2018 $5,922
2017 $6,794
2016 $1,753
2015 $1,243
2014 $562
2013 $341
2012 $116
2011 $136
2010 $107
2009 $87
Gilead Sciences Quarterly Other Non-Current Liabilities
(Millions of US $)
2025-06-30 $2,149
2025-03-31 $2,156
2024-12-31 $2,125
2024-09-30 $782
2024-06-30 $2,156
2024-03-31 $1,967
2023-12-31 $2,039
2023-09-30 $2,088
2023-06-30 $2,610
2023-03-31 $5,052
2022-12-31 $3,916
2022-09-30 $3,982
2022-06-30 $3,888
2022-03-31 $4,793
2021-12-31 $4,767
2021-09-30 $4,642
2021-06-30 $5,772
2021-03-31 $5,022
2020-12-31 $5,016
2020-09-30 $5,020
2020-06-30 $5,107
2020-03-31 $6,585
2019-12-31 $6,115
2019-09-30 $5,852
2019-06-30 $5,837
2019-03-31 $7,269
2018-12-31 $5,922
2018-09-30 $6,018
2018-06-30 $6,001
2018-03-31 $6,832
2017-12-31 $6,794
2017-09-30 $2,037
2017-06-30 $1,942
2017-03-31 $2,181
2016-12-31 $1,753
2016-09-30 $1,621
2016-06-30 $1,527
2016-03-31 $1,385
2015-12-31 $1,243
2015-09-30 $1,027
2015-06-30 $883
2015-03-31 $713
2014-12-31 $562
2014-09-30 $417
2014-06-30 $338
2014-03-31 $226
2013-12-31 $341
2013-09-30 $120
2013-06-30 $123
2013-03-31 $110
2012-12-31 $116
2012-09-30 $129
2012-06-30 $127
2012-03-31 $141
2011-12-31 $136
2011-09-30 $117
2011-06-30 $117
2011-03-31 $113
2010-12-31 $107
2010-09-30 $81
2010-06-30 $66
2010-03-31 $67
2009-12-31 $87
2009-09-30 $68
2009-06-30 $65
2009-03-31 $57
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $144.107B $28.754B
Gilead Sciences is a pioneer in developing drugs for the treatment of human immunodeficiency virus, liver diseases, hematology/oncology diseases and inflammation/respiratory diseases. The company has a strong HIV franchise with key HIV/AIDS therapies like tenofovir alafenamide based products - Genvoya, Odefsey, Descovy, Biktarvy and Truvada. The portfolio also includes hepatitis C virus drugs like Harvoni and Epclusa and HBV drug. The first cell therapy approved for the treatment of adult patients with relapsed or refractory large B-cell lymphoma, has diversified Gilead's portfolio. Tecartus, another CAR T-cell therapy, was granted an accelerated approval in the United States for the treatment of relapsed or refractory mantle cell lymphoma. The company is also working on diversifying and growing its business beyond antivirals into other therapeutic areas. Gilead is also making inroads in the oncology space with strategic collaborations and acquisitions.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $249.536B 18.20
Amgen (AMGN) United States $159.226B 13.56
Vertex Pharmaceuticals (VRTX) United States $101.905B 26.27
Bristol Myers Squibb (BMY) United States $98.576B 7.20
GSK (GSK) United Kingdom $81.670B 9.50
CSL (CSLLY) Australia $69.852B 0.00
Regeneron Pharmaceuticals (REGN) United States $63.397B 15.42
Alnylam Pharmaceuticals (ALNY) United States $61.286B 0.00
Argenex SE (ARGX) Netherlands $40.620B 71.45
Insmed (INSM) United States $28.028B 0.00
BioNTech SE (BNTX) Germany $26.629B 0.00
Royalty Pharma (RPRX) United States $21.175B 8.27
Biogen (BIIB) United States $20.397B 8.69
Incyte (INCY) United States $16.897B 21.52
Genmab (GNMSF) Denmark $16.145B 14.30
Genmab (GMAB) Denmark $15.666B 14.28
Illumina (ILMN) United States $15.261B 23.87
Ascendis Pharma (ASND) Denmark $11.801B 0.00
BioMarin Pharmaceutical (BMRN) United States $11.150B 15.74
QIAGEN (QGEN) Netherlands $10.921B 20.94
Exelixis (EXEL) United States $10.421B 18.79
Swedish Orphan Biovitrum (BIOVF) Sweden $10.313B 22.81
Moderna (MRNA) United States $10.202B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $8.977B 0.00
Exact Sciences (EXAS) United States $8.837B 0.00
Bio-Techne Corp (TECH) United States $8.465B 31.21
Halozyme Therapeutics (HALO) United States $8.376B 14.73
Roivant Sciences (ROIV) United Kingdom $8.029B 0.00
Guardant Health (GH) United States $7.642B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.311B 39.01
Anbio Biotechnology (NNNN) Germany $7.107B 0.00
Revolution Medicines (RVMD) United States $6.819B 0.00
Rhythm Pharmaceuticals (RYTM) United States $6.754B 0.00
Repligen (RGEN) United States $6.731B 73.40
Bio-Rad Laboratories (BIO.B) United States $6.723B 24.56
Legend Biotech (LEGN) United States $6.529B 0.00
Axsome Therapeutics (AXSM) United States $5.845B 0.00
Avidity Biosciences (RNA) United States $5.746B 0.00
Abivax SA (ABVX) France $5.623B 0.00
Nuvalent (NUVL) United States $5.311B 0.00
Merus (MRUS) Netherlands $5.041B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.804B 0.00
Alkermes (ALKS) Ireland $4.797B 13.33
TG Therapeutics (TGTX) United States $4.565B 77.76
Cytokinetics (CYTK) United States $4.553B 0.00
Ascentage Pharma Group - (AAPG) China $4.434B 0.00
Zealand Pharma (ZLDPF) Denmark $4.332B 4.28
Krystal Biotech (KRYS) United States $4.217B 29.61
ACADIA Pharmaceuticals (ACAD) United States $4.182B 38.73
Vaxcyte (PCVX) United States $4.143B 0.00
Telix Pharmaceuticals (TLX) Australia $4.091B 0.00
ADMA Biologics Inc (ADMA) United States $4.081B 29.48
Arcellx (ACLX) United States $3.980B 0.00
PTC Therapeutics (PTCT) United States $3.886B 6.45
Akero Therapeutics (AKRO) United States $3.863B 0.00
Zai Lab (ZLAB) United States $3.776B 0.00
Apellis Pharmaceuticals (APLS) United States $3.488B 0.00
Protagonist Therapeutics (PTGX) United States $3.486B 80.06
MoonLake Immunotherapeutics (MLTX) Switzerland $3.479B 0.00
Mirum Pharmaceuticals (MIRM) United States $3.469B 0.00
Metsera (MTSR) United States $3.446B 0.00
Scholar Rock Holding (SRRK) United States $3.325B 0.00
Jyong Biotech (MENS) Taiwan $3.281B 0.00
Ligand Pharmaceuticals (LGND) United States $3.083B 0.00
Kymera Therapeutics (KYMR) United States $3.045B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.944B 0.00
Bavarian Nordic (BVNRY) Denmark $2.911B 15.38
Viking Therapeutics (VKTX) United States $2.885B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.869B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.845B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.810B 0.00
Immunovant (IMVT) United States $2.587B 0.00
Alvotech (ALVO) Luxembourg $2.554B 19.25
Kiniksa Pharmaceuticals (KNSA) United Kingdom $2.489B 839.50
Tarsus Pharmaceuticals (TARS) United States $2.388B 0.00
Liquidia Technologies (LQDA) United States $2.350B 0.00
Amicus Therapeutics (FOLD) United States $2.343B 0.00
Denali Therapeutics (DNLI) United States $2.227B 0.00
Agios Pharmaceuticals (AGIO) United States $2.219B 0.00
IDEAYA Biosciences (IDYA) United States $2.159B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.145B 12.03
Celcuity (CELC) United States $2.137B 0.00
ImmunityBio (IBRX) United States $2.117B 0.00
Disc Medicine (IRON) United States $2.077B 0.00
Belite Bio (BLTE) United States $2.076B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.075B 0.00
CG Oncology (CGON) United States $1.981B 0.00
ANI Pharmaceuticals (ANIP) United States $1.978B 17.73
Sarepta Therapeutics (SRPT) United States $1.960B 0.00
Mesoblast (MESO) Australia $1.942B 0.00
Adaptive Biotechnologies (ADPT) United States $1.923B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.893B 0.00
Vericel (VCEL) United States $1.788B 295.33
Certara (CERT) United States $1.730B 31.68
Cidara Therapeutics (CDTX) United States $1.711B 0.00
Apogee Therapeutics (APGE) United States $1.676B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.646B 0.00
Beam Therapeutics (BEAM) United States $1.620B 0.00
Twist Bioscience (TWST) United States $1.598B 0.00
Travere Therapeutics (TVTX) United States $1.586B 0.00
WAVE Life Sciences (WVE) Singapore $1.553B 0.00
Biohaven (BHVN) United States $1.553B 0.00
Edgewise Therapeutics (EWTX) United States $1.540B 0.00
Viridian Therapeutics (VRDN) United States $1.472B 0.00
Celldex Therapeutics (CLDX) United States $1.462B 0.00
Vera Therapeutics (VERA) United States $1.443B 0.00
Janux Therapeutics (JANX) United States $1.442B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.364B 0.00
89BIO (ETNB) United States $1.363B 0.00
Cogent Biosciences (COGT) United States $1.340B 0.00
NovoCure (NVCR) Jersey $1.332B 0.00
AbCellera Biologics (ABCL) Canada $1.285B 0.00
Dynavax Technologies (DVAX) United States $1.284B 54.75
Novavax (NVAX) United States $1.239B 3.35
Pharvaris (PHVS) Netherlands $1.221B 0.00
CureVac (CVAC) Germany $1.216B 5.65
MannKind (MNKD) United States $1.209B 35.82
GRAIL (GRAL) United States $1.195B 0.00
Pacira BioSciences (PCRX) United States $1.141B 12.09
LENZ Therapeutics (LENZ) United States $1.137B 0.00
Structure Therapeutics (GPCR) United States $1.116B 0.00
Arcus Biosciences (RCUS) United States $1.115B 0.00
Intellia Therapeutics (NTLA) United States $1.087B 0.00
Precigen (PGEN) United States $1.085B 0.00
Zymeworks (ZYME) United States $1.082B 0.00
Stoke Therapeutics (STOK) United States $1.078B 23.15
Sionna Therapeutics (SION) United States $1.048B 0.00
MiMedx (MDXG) United States $1.040B 23.43
Spyre Therapeutics (SYRE) United States $1.014B 0.00
CorMedix Inc (CRMD) United States $1.012B 18.08
Praxis Precision Medicines (PRAX) United States $0.976B 0.00
Mineralys Therapeutics (MLYS) United States $0.969B 0.00
Upstream Bio (UPB) United States $0.956B 0.00
Oric Pharmaceuticals (ORIC) United States $0.941B 0.00
Nuvation Bio (NUVB) United States $0.938B 0.00
Iovance Biotherapeutics (IOVA) United States $0.919B 0.00
Urogen Pharma (URGN) United States $0.915B 0.00
Geron (GERN) United States $0.912B 0.00
Trevi Therapeutics (TRVI) United States $0.912B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.892B 0.00
Pharming Group (PHAR) Netherlands $0.867B 0.00
Immunome (IMNM) United States $0.866B 0.00
Sana Biotechnology (SANA) United States $0.856B 0.00
UniQure (QURE) Netherlands $0.853B 0.00
Anavex Life Sciences (AVXL) United States $0.820B 0.00
ArriVent BioPharma (AVBP) United States $0.807B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.800B 0.00
NeoGenomics (NEO) United States $0.798B 0.00
Tango Therapeutics (TNGX) United States $0.780B 0.00
Niagen Bioscience (NAGE) United States $0.779B 75.15
Oxford BioMedica (OXBDF) United Kingdom $0.779B 0.00
Pharming Group (PHGUF) Netherlands $0.778B 0.00
Oculis Holding AG (OCS) Switzerland $0.777B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.777B 0.00
Dianthus Therapeutics (DNTH) United States $0.761B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.747B 0.00
Nurix Therapeutics (NRIX) United States $0.738B 0.00
BGM Group (BGM) China $0.731B 0.00
Gyre Therapeutics (GYRE) United States $0.727B 151.00
Day One Biopharmaceuticals (DAWN) United States $0.715B 0.00
Zenas BioPharma (ZBIO) United States $0.713B 0.00
Fortrea Holdings (FTRE) United States $0.703B 12.49
Ginkgo Bioworks Holdings (DNA) United States $0.696B 0.00
Arbutus Biopharma (ABUS) United States $0.686B 0.00
Immatics (IMTX) Germany $0.684B 0.00
GH Research (GHRS) Ireland $0.676B 0.00
Kura Oncology (KURA) United States $0.646B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Bicara Therapeutics (BCAX) United States $0.635B 0.00
MeiraGTx Holdings (MGTX) United States $0.632B 0.00
Tyra Biosciences (TYRA) United States $0.624B 0.00
Keros Therapeutics (KROS) United States $0.616B 48.94
Vir Biotechnology (VIR) United States $0.608B 0.00
Rezolute (RZLT) United States $0.605B 0.00
Terns Pharmaceuticals (TERN) United States $0.592B 0.00
Maze Therapeutics (MAZE) United States $0.580B 0.00
Castle Biosciences (CSTL) United States $0.579B 57.06
AnaptysBio (ANAB) United States $0.570B 0.00
Palvella Therapeutics (PVLA) United States $0.567B 0.00
Rapport Therapeutics (RAPP) United States $0.545B 0.00
Myriad Genetics (MYGN) United States $0.542B 0.00
Arvinas (ARVN) United States $0.536B 0.00
Verastem (VSTM) United States $0.531B 0.00
Opthea (OPT) Australia $0.525B 0.00
Septerna (SEPN) United States $0.522B 0.00
Kodiak Sciences (KOD) United States $0.513B 0.00
Cytek Biosciences (CTKB) United States $0.510B 0.00
Emergent Biosolutions (EBS) United States $0.497B 4.07
Gossamer Bio (GOSS) United States $0.493B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.491B 0.00
ATyr Pharma (ATYR) United States $0.485B 0.00
Alumis (ALMS) United States $0.479B 0.00
MBX Biosciences (MBX) United States $0.475B 0.00
Tectonic Therapeutic (TECX) United States $0.475B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.475B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.466B 0.00
Prothena (PRTA) Ireland $0.461B 0.00
Eton Pharmaceuticals (ETON) United States $0.458B 0.00
Cullinan Therapeutics (CGEM) United States $0.453B 0.00
ITeos Therapeutics (ITOS) United States $0.451B 0.00
PureTech Health (PRTC) United States $0.444B 0.00
Solid Biosciences (SLDB) United States $0.441B 0.00
Replimune (REPL) United States $0.437B 0.00
Prime Medicine (PRME) United States $0.433B 0.00
Erasca (ERAS) United States $0.426B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.425B 0.00
REGENXBIO (RGNX) United States $0.410B 0.00
Inventiva S.A (IVA) France $0.408B 0.00
Kamada (KMDA) Israel $0.405B 20.72
Rocket Pharmaceuticals (RCKT) United States $0.402B 0.00
Aura Biosciences (AURA) United States $0.402B 0.00
XOMA Royalty (XOMA) United States $0.396B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.394B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.388B 0.00
Compass Therapeutics (CMPX) United States $0.387B 0.00
I-Mab (IMAB) United States $0.385B 0.00
Absci (ABSI) United States $0.383B 0.00
Olema Pharmaceuticals (OLMA) United States $0.380B 0.00
Northwest Biotherapeutics (NWBO) United States $0.368B 0.00
Abeona Therapeutics (ABEO) United States $0.365B 7.73
Astria Therapeutics (ATXS) United States $0.358B 0.00
Fulcrum Therapeutics (FULC) United States $0.353B 0.00
Inhibrx Biosciences (INBX) United States $0.350B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.349B 0.00
CytomX Therapeutics (CTMX) United States $0.335B 3.62
Benitec Biopharma (BNTC) United States $0.333B 0.00
Amarin (AMRN) Ireland $0.328B 0.00
Candel Therapeutics (CADL) United States $0.318B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.316B 0.00
DiaMedica Therapeutics (DMAC) United States $0.307B 0.00
Bright Minds Biosciences (DRUG) United States $0.297B 0.00
Ocugen (OCGN) United States $0.295B 0.00
Design Therapeutics (DSGN) United States $0.293B 0.00
Cartesian Therapeutics (RNAC) United States $0.285B 0.00
Foghorn Therapeutics (FHTX) United States $0.285B 0.00
Neurogene (NGNE) United States $0.282B 0.00
Contineum Therapeutics (CTNM) United States $0.282B 0.00
Crescent Biopharma (CBIO) United States $0.282B 0.00
Atea Pharmaceuticals (AVIR) United States $0.280B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.278B 12.50
Vor Biopharma (VOR) $0.275B 0.00
Lifecore Biomedical (LFCR) United States $0.270B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.266B 0.00
Neumora Therapeutics (NMRA) United States $0.266B 0.00
Puma Biotechnology (PBYI) United States $0.263B 5.33
Mereo BioPharma Group - (MREO) United Kingdom $0.262B 0.00
DBV Technologies S.A (DBVT) France $0.261B 0.00
Codexis (CDXS) United States $0.255B 0.00
Tvardi Therapeutics (TVRD) United States $0.250B 0.00
Allogene Therapeutics (ALLO) United States $0.249B 0.00
Editas Medicine (EDIT) United States $0.245B 0.00
ScPharmaceuticals (SCPH) United States $0.244B 0.00
Jade Biosciences (JBIO) United States $0.241B 0.00
Prima BioMed (IMMP) Australia $0.241B 0.00
Alpha Teknova (TKNO) United States $0.240B 0.00
Humacyte (HUMA) United States $0.239B 0.00
Annexon (ANNX) United States $0.238B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.233B 0.00
Alector (ALEC) United States $0.230B 0.00
Adherex Technologies (FENC) United States $0.227B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.226B 0.00
Sagimet Biosciences (SGMT) United States $0.225B 0.00
Entrada Therapeutics (TRDA) United States $0.223B 0.00
Adocia (ADOCY) France $0.216B 0.00
Aardvark Therapeutics (AARD) United States $0.211B 0.00
AC Immune (ACIU) Switzerland $0.211B 0.00
GENFIT S.A (GNFT) France $0.206B 0.00
Innate Pharma S.A (IPHA) France $0.206B 0.00
EnGene Holdings (ENGN) Canada $0.200B 0.00
Monopar Therapeutics (MNPR) United States $0.196B 0.00
Tenaya Therapeutics (TNYA) United States $0.189B 0.00
Ventyx Biosciences (VTYX) United States $0.189B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.187B 0.00
Elicio Therapeutics (ELTX) United States $0.187B 0.00
Voyager Therapeutics (VYGR) United States $0.186B 0.00
C4 Therapeutics (CCCC) United States $0.186B 0.00
SELLAS Life Sciences (SLS) United States $0.185B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.184B 0.00
Instil Bio (TIL) United States $0.179B 0.00
Rapt Therapeutics (RAPT) United States $0.177B 0.00
Sangamo Therapeutics (SGMO) United States $0.173B 0.00
Caribou Biosciences (CRBU) United States $0.171B 0.00
Immuneering (IMRX) United States $0.168B 0.00
Tevogen Bio Holdings (TVGN) United States $0.166B 0.00
Nkarta (NKTX) United States $0.165B 0.00
Greenwich LifeSciences (GLSI) United States $0.162B 0.00
Nuvectis Pharma (NVCT) United States $0.161B 0.00
BioAge Labs (BIOA) United States $0.161B 0.00
Seres Therapeutics (MCRB) United States $0.160B 0.00
Actuate Therapeutics (ACTU) United States $0.159B 0.00
Kyverna Therapeutics (KYTX) United States $0.155B 0.00
Black Diamond Therapeutics (BDTX) United States $0.154B 11.78
Cellectis S.A (CLLS) France $0.154B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.153B 0.00
MaxCyte (MXCT) United States $0.151B 0.00
Cardiff Oncology (CRDF) United States $0.150B 0.00
BioHarvest Sciences (BHST) Canada $0.149B 0.00
Theratechnologies (THTX) Canada $0.149B 0.00
Climb Bio (CLYM) United States $0.148B 0.00
Cabaletta Bio (CABA) United States $0.146B 0.00
Cognition Therapeutics (CGTX) United States $0.146B 0.00
TuHURA Biosciences (HURA) United States $0.146B 0.00
Agenus (AGEN) United States $0.146B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.145B 0.00
Molecular Partners AG (MOLN) Switzerland $0.143B 0.00
Forte Biosciences (FBRX) United States $0.138B 0.00
Zura Bio (ZURA) United States $0.136B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.135B 0.00
Alpha Cognition (ACOG) Canada $0.133B 0.00
Coherus Oncology (CHRS) United States $0.131B 0.00
Anika Therapeutics (ANIK) United States $0.130B 0.00
Genelux (GNLX) United States $0.130B 0.00
Fate Therapeutics (FATE) United States $0.128B 0.00
Citius Oncology (CTOR) United States $0.128B 0.00
Compugen (CGEN) Israel $0.128B 0.00
Scilex Holding (SCLX) United States $0.119B 0.00
IO Biotech (IOBT) Denmark $0.117B 0.00
Seer (SEER) United States $0.116B 0.00
Coya Therapeutics (COYA) United States $0.110B 0.00
Skye Bioscience (SKYE) United States $0.110B 0.00
Adagene (ADAG) China $0.107B 0.00
Oncobiologics (OTLK) United States $0.107B 0.00
Biomea Fusion (BMEA) United States $0.107B 0.00
Spero Therapeutics (SPRO) United States $0.105B 0.00
23andMe Holding (MEHCQ) United States $0.104B 0.00
HilleVax (HLVX) United States $0.104B 0.00
Inovio Pharmaceuticals (INO) United States $0.102B 0.00
Oncolytics Biotech (ONCY) Canada $0.101B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.101B 0.00
BioStem Technologies (BSEM) $0.100B 5.23
TScan Therapeutics (TCRX) United States $0.098B 0.00
XBiotech (XBIT) United States $0.098B 0.00
Alto Neuroscience (ANRO) United States $0.097B 0.00
Connect Biopharma Holdings (CNTB) United States $0.096B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.096B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.095B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.095B 0.00
VistaGen Therapeutics (VTGN) United States $0.094B 0.00
Immunic (IMUX) United States $0.093B 0.00
Equillium (EQ) United States $0.093B 0.00
Elutia (ELUT) United States $0.090B 0.00
Entera Bio (ENTX) Israel $0.089B 0.00
Pliant Therapeutics (PLRX) United States $0.089B 0.00
OKYO Pharma (OKYO) $0.088B 0.00
Quince Therapeutics (QNCX) United States $0.086B 0.00
Celularity (CELU) United States $0.086B 0.00
CervoMed (CRVO) United States $0.085B 0.00
Nautilus Biotechnology (NAUT) United States $0.084B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.082B 0.00
Atara Biotherapeutics (ATRA) United States $0.081B 0.00
EXoZymes (EXOZ) United States $0.078B 0.00
Whitehawk Therapeutics (WHWK) United States $0.078B 0.00
BioXcel Therapeutics (BTAI) United States $0.076B 0.00
Applied Therapeutics (APLT) United States $0.074B 0.00
Sutro Biopharma (STRO) United States $0.072B 0.00
ABVC BioPharma (ABVC) United States $0.072B 0.00
BeyondSpring (BYSI) United States $0.071B 0.00
Opus Genetics (IRD) United States $0.069B 0.00
TELA Bio (TELA) United States $0.068B 0.00
Ovid Therapeutics (OVID) United States $0.068B 0.00
Artiva Biotherapeutics (ARTV) United States $0.068B 0.00
MiNK Therapeutics (INKT) United States $0.068B 0.00
Genenta Science S.p.A (GNTA) Italy $0.067B 0.00
Fortress Biotech (FBIO) United States $0.067B 0.00
Repare Therapeutics (RPTX) Canada $0.067B 0.00
Immix Biopharma (IMMX) United States $0.066B 0.00
ZIVO Bioscience (ZIVO) United States $0.066B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.065B 0.00
Invivyd (IVVD) United States $0.063B 0.00
MediciNova (MNOV) United States $0.063B 0.00
INmune Bio (INMB) United States $0.062B 0.00
Adlai Nortye (ANL) Cayman Islands $0.062B 0.00
Cue Biopharma (CUE) United States $0.062B 0.00
Adverum Biotechnologies (ADVM) United States $0.061B 0.00
Aligos Therapeutics (ALGS) United States $0.061B 0.00
InflaRx (IFRX) Germany $0.060B 0.00
KALA BIO (KALA) United States $0.060B 0.00
Werewolf Therapeutics (HOWL) United States $0.059B 0.00
Adicet Bio (ACET) United States $0.057B 0.00
Earth Science Tech (ETST) United States $0.057B 0.00
ImageneBio (IMA) United States $0.057B 0.00
Precision BioSciences (DTIL) United States $0.056B 0.00
ALX Oncology Holdings (ALXO) United States $0.055B 0.00
PDS Biotechnology (PDSB) United States $0.054B 0.00
Clene (CLNN) United States $0.053B 0.00
Quantum Biopharma (QNTM) Canada $0.052B 0.00
VTv Therapeutics (VTVT) United States $0.048B 0.00
Barinthus Biotherapeutics (BRNS) United States $0.048B 0.00
Propanc Biopharma Inc (PPCB) Australia $0.047B 0.00
Annovis Bio (ANVS) United States $0.046B 0.00
Kalaris Therapeutics (KLRS) United States $0.046B 0.00
Grace Therapeutics (GRCE) Canada $0.046B 0.00
Lantern Pharma (LTRN) United States $0.045B 0.00
Alterity Therapeutics - (ATHE) Australia $0.045B 0.00
Radiopharm Theranostics - (RADX) Australia $0.045B 0.00
Jasper Therapeutics (JSPR) United States $0.044B 0.00
Medicus Pharma (MDCX) United States $0.044B 0.00
Shattuck Labs (STTK) United States $0.043B 0.00
Generation Bio (GBIO) United States $0.042B 0.00
Senti Biosciences (SNTI) United States $0.042B 0.00
PepGen (PEPG) United States $0.041B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.041B 0.00
Mersana Therapeutics (MRSN) United States $0.040B 0.00
Rani Therapeutics Holdings (RANI) United States $0.039B 0.00
Renovaro (RENB) United States $0.039B 0.00
Exicure (XCUR) United States $0.039B 0.00
CalciMedica (CALC) United States $0.039B 0.00
Pluri (PLUR) Israel $0.038B 0.00
OnKure Therapeutics (OKUR) United States $0.037B 0.00
X4 Pharmaceuticals (XFOR) United States $0.036B 0.00
Xilio Therapeutics (XLO) United States $0.035B 0.00
RenovoRx (RNXT) United States $0.033B 0.00
Estrella Immunopharma (ESLA) United States $0.033B 0.00
CAMP4 Therapeutics (CAMP) United States $0.032B 0.00
Clearside Biomedical (CLSD) United States $0.032B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.031B 0.00
AN2 Therapeutics (ANTX) United States $0.030B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.030B 0.00
Kezar Life Sciences (KZR) United States $0.029B 0.00
Promis Neurosciences (PMN) Canada $0.028B 0.00
Dare Bioscience (DARE) United States $0.028B 0.00
Dyadic (DYAI) United States $0.028B 0.00
Tenax Therapeutics (TENX) United States $0.028B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.027B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.027B 0.00
Rein Therapeutics (RNTX) United States $0.026B 0.00
Boundless Bio (BOLD) United States $0.026B 0.00
Cadrenal Therapeutics (CVKD) United States $0.025B 0.00
Rallybio (RLYB) United States $0.025B 0.00
FibroBiologics (FBLG) United States $0.025B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.024B 0.00
Passage Bio (PASG) United States $0.024B 0.00
Tharimmune (THAR) United States $0.023B 0.00
Q32 Bio (QTTB) United States $0.023B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.023B 0.00
Synaptogenix (TAOX) United States $0.022B 0.00
Lisata Therapeutics (LSTA) United States $0.022B 0.00
Cingulate (CING) United States $0.022B 0.00
SAB Biotherapeutics (SABS) United States $0.021B 0.00
BioAtla (BCAB) United States $0.021B 0.00
Aytu BioPharma (AYTU) United States $0.020B 0.00
Abpro Holdings (ABP) United States $0.020B 0.00
Curis (CRIS) United States $0.020B 0.00
Bionano Genomics (BNGO) United States $0.019B 0.00
Femasys (FEMY) United States $0.018B 0.00
Moleculin Biotech (MBRX) United States $0.018B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.018B 0.00
LakeShore Biopharma (LSB) China $0.017B 0.00
Hoth Therapeutics (HOTH) United States $0.017B 0.00
Edesa Biotech (EDSA) Canada $0.017B 0.00
Chemomab Therapeutics (CMMB) Israel $0.017B 0.00
Synlogic (SYBX) United States $0.016B 0.00
Imunon (IMNN) United States $0.016B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.016B 0.00
Athira Pharma (ATHA) United States $0.016B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.016B 0.00
Cocrystal Pharma (COCP) United States $0.015B 0.00
MetaVia (MTVA) United States $0.015B 0.00
Lexaria Bioscience (LEXX) Canada $0.015B 0.00
IBio (IBIO) United States $0.015B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.015B 0.00
Intensity Therapeutics (INTS) United States $0.015B 0.00
Soligenix (SNGX) United States $0.014B 0.00
NextCure (NXTC) United States $0.014B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.013B 0.00
Allarity Therapeutics (ALLR) United States $0.013B 0.00
IMMURON (IMRN) Australia $0.012B 0.00
Longeveron (LGVN) United States $0.012B 0.00
Biorestorative Therapies (BRTX) United States $0.012B 0.00
GeoVax Labs (GOVX) United States $0.012B 0.00
Gelteq (GELS) Australia $0.012B 0.00
Leap Therapeutics (LPTX) United States $0.011B 0.00
Beyond Air (XAIR) United States $0.011B 0.00
BioCardia (BCDA) United States $0.011B 0.00
IN8bio (INAB) United States $0.010B 0.00
Sensei Biotherapeutics (SNSE) United States $0.010B 0.00
Dogwood Therapeutics (DWTX) United States $0.009B 0.00
Bolt Biotherapeutics (BOLT) United States $0.009B 0.00
Aprea Therapeutics (APRE) United States $0.009B 0.00
Portage Biotech (PRTG) $0.009B 0.00
Advanced Biomed (ADVB) United States $0.009B 0.00
Biofrontera (BFRI) United States $0.009B 0.00
COSCIENS Biopharma (CSCI) Canada $0.009B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.008B 0.00
Adial Pharmaceuticals (ADIL) United States $0.008B 0.00
Mainz Biomed (MYNZ) Germany $0.008B 0.00
Avalon GloboCare (ALBT) United States $0.008B 0.00
Cyclerion Therapeutics (CYCN) United States $0.008B 0.00
Mustang Bio (MBIO) United States $0.007B 0.00
Novogen (KZIA) Australia $0.007B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.007B 0.00
HCW Biologics (HCWB) United States $0.007B 0.00
BioAffinity Technologies (BIAF) United States $0.007B 0.00
Evogene (EVGN) Israel $0.007B 0.00
Alzamend Neuro (ALZN) United States $0.007B 0.00
Aptevo Therapeutics (APVO) United States $0.007B 0.00
Artelo Biosciences (ARTL) United States $0.007B 0.00
Apollomics (APLM) United States $0.007B 0.00
Palisade Bio (PALI) United States $0.007B 0.00
Titan Pharmaceuticals (TTNP) United States $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.006B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.006B 0.00
Polyrizon (PLRZ) Israel $0.006B 0.00
Silo Pharma (SILO) United States $0.006B 0.00
Ensysce Biosciences (ENSC) United States $0.006B 0.00
Psyence Biomedical (PBM) Canada $0.006B 0.00
Arcadia Biosciences (RKDA) United States $0.006B 0.00
Purple Biotech (PPBT) Israel $0.006B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
VivoSim Labs (VIVS) United States $0.005B 0.00
GENPREX (GNPX) United States $0.005B 0.00
Galecto (GLTO) Denmark $0.004B 0.00
BRIACELL THERAP (BCTX) Canada $0.004B 0.00
Onconetix (ONCO) United States $0.004B 0.00
Revelation Biosciences (REVB) United States $0.004B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.004B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.004B 0.00
Bone Biologics (BBLG) United States $0.004B 0.00
GT Biopharma (GTBP) United States $0.004B 0.00
Enveric Biosciences (ENVB) United States $0.004B 0.00
Dermata Therapeutics (DRMA) United States $0.004B 0.00
GRI Bio (GRI) United States $0.004B 0.00
CNS Pharmaceuticals (CNSP) United States $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.003B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Atrinsic (PTIX) United States $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00